Author:
Nedorubova I. A,Bukharova T. B,Vasilyev A. V,Goldshtein D. V,Kulakov A. A
Abstract
Gene-activated bone grafts and substitutes are promising tools for the bone defect healing, which are capable to induce prolonged production of growth factors with a therapeutic effect at physiological concentrations. Non-viral methods of delivering plasmid constructs with target genes are the safest for clinical use, but their efficiency is lower in comparison with viral vectors. To solve the problem of plasmid delivery into cells, some systems with a high transfection capacity and ensure sufficient cell viability are being developed. Moreover, there are different approaches to improve the level of expression of target genes and targeted delivery to the bone defect in order to achieve local therapeutic concentrations. This review considers approaches which are aimed to increase the efficiency of bone tissue regeneration methods based on non-viral delivery systems for osteoinduction genes using the example of the bone morphogenetic protein-2 gene.
Subject
Transplantation,Cell Biology,Molecular Biology,Biomedical Engineering,Surgery,Biotechnology
Reference87 articles.
1. Kumar P., Vinitha B., Fathima G. Bone grafts in dentistry. J. Pharm. Bioallied Sci. 2013; 5(5): 125-7.
2. Деев Р.В., Дробышев А.Ю., Бозо И.Я. Ординарные и активированные остеопластические материалы. Вестник травматологии и ортопедии имени Н.Н. Приорова 2015; 1: 51-69.
3. Carreira A.C., Zambuzzi W.F., Rossi M.C. et al. Bone morphogenetic proteins: promising molecules for bone healing, bioengineering, and regenerative medicine. Vitam. Horm. 2015; 99: 293-322.
4. Schmidt-Bleek K., Willie B.M., Schwabe P. et al. BMPs in bone regeneration: Less is more effective, a paradigm-shift. Cytokine Growth Factor Rev. 2016; 27: 141-8.
5. Salazar V.S., Gamer L.W., Rosen V. BMP signalling in skeletal development, disease and repair. Nat. Rev. Endocrinol. 2016; 12(4): 203-21.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献